Key facts
- This page summarizes Moshe Orenstein's Form 3 filing for Nayax Ltd. (NYAX).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 30 Oct 2026, 08:06.
Moshe Orenstein - 05 Oct 2026 Form 3 Insider Report for Nayax Ltd. (NYAX)
- Reporting owner signature
- /s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Moshe Orenstein filed Form 3 for Nayax Ltd. (NYAX) on 30 Oct 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002161738
Primary reporting owner
Orenstein Moshe
- Relationship
- CCO
- Address
- ARIK EINSTEIN 3, HERZLIYA, ISRAEL
- Signature
- /s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact
- Signature date
- 30 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NYAX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,325
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
NYAX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,032
- Date
- 05 Oct 2026
- Ownership
- Direct
NYAX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 953
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F2
NYAX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,049
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F3
NYAX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,623
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F4
NYAX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 05 Oct 2026
- Ownership
- Direct
- Footnotes
- F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NYAX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Oct 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,000
- Exercise price
- $38.11
- Footnotes
- F6, F7
NYAX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Oct 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,000
- Exercise price
- $38.11
- Footnotes
- F8, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
The shares are held on the Tel Aviv Stock Exchange.
Footnote F2
The Reporting Person was granted 953 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 302 RSUs are vested, and the remaining 651 RSUs vest in three equal quarterly installments beginning on December 26, 2026 and ending on June 26, 2027, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
Footnote F3
The Reporting Person was granted 1,049 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 174 RSUs are vested, and the remaining 875 RSUs vest in seven equal quarterly installments beginning on December 25, 2026 and ending on June 25, 2028, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
Footnote F4
The Reporting Person was granted 1,623 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 355 RSUs are vested, and the remaining 1,268 RSUs vest in eleven equal quarterly installments beginning on December 3, 2026 and ending on June 3, 2029, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
Footnote F5
The Reporting Person was granted 10,000 restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share of Nayax Ltd. (the "Company"). 2,000 RSUs vest on March 15, 2027, and the remaining 8,000 RSUs vest in four equal annual installments over the following four years, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
Footnote F6
The Stock Options are Fully vested and immediately exercisable
Footnote F7
The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
Footnote F8
The Reporting Person holds 5,000 stock options to purchase ordinary shares of Nayax Ltd. (the "Company"). Of these options, 4,500 are vested and currently exercisable, and the remaining 500 options will vest on December 31, 2026, subject to the Reporting Person's continued service to the Company or its subsidiaries through such date.
Footnote F9
The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
SEC remarks
This Form 3 is being filed to report the Reporting Person beneficial ownership of securities of the Issuer as of the date the Reporting Person became subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934.